Project Number 5R01NS074593-03 Agency/Funding Organization NINDS Funding Year 2013 View Full Project Details for AUTOPHAGIC CLEARANCE OF ABERRANT TAU: BIOCHEMICAL AND THERAPEUTIC IMPLICATIONS Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 6. Autophagy, Endocytosis and Membrane Trafficking c. Endosomal/Lysosomal Dysfunction Researcher and Organization Principal Investigator DUFF, KAREN E Principal Investigator First Name KAREN E Principal Investigator Last Name DUFF Awardee Organization COLUMBIA UNIVERSITY Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PA-10-067: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $406,380 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official CORRIVEAU, RODERICK A Related Resources Repository [AlzPED] Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo.
